Characteristics of NSCLC Patients Treated in First Line Treatment with Tyrosine Kinase Inhibitors (TKI) - Real Data from the Czech Republic

• Authors: SKŘIČKOVÁ Jana; CHLOUPKOVÁ Renata; BORTLÍČEK Zbyněk; PESEK M.; KOLEK V.; HEJDUK Karel; KOUBKOVA L.; ČERNOVSKA M.; KREJCI J.; ZEMANOVA M.; HAVEL L.; ROUBEC J.; HRNCIARIK M.; SALAJKA F.; COUPKOVA H.; ŠATÁNKOVÁ Monika; BENEJOVÁ Andrea; GRYGARKOVA I.; OPALKA P.
• Year of publication: 2017
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: Characteristics of NSCLC Patients Treated in First Line Treatment with Tyrosine Kinase Inhibitors (TKI) - Real Data from the Czech Republic.